Active Ingredient(s): Semaglutide
FDA Approved: * September 20, 2019
Pharm Company: * NOVO NORDISK INC
Category: Diabetes

Semaglutide, sold under the brand name Ozempic among others, is an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management.[15][16][17] Semaglutide acts like human glucagon-like peptide-1 (GLP-1) in that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidia... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rybelsus 3 mg Oral Tablet
NDC: 0169-4303
Novo Nordisk
Rybelsus 7 mg Oral Tablet
NDC: 0169-4307
Novo Nordisk
Rybelsus 14 mg Oral Tablet
NDC: 0169-4314
Novo Nordisk

Related Brands

Drugs with the same active ingredients